- Details
-
Category: Bio Pharmaceuticals
Kemwell, a provider of contract manufacturing and development services for pharmaceutical products globally, is building a biopharmaceutical manufacturing plant in Bangalore with an investment of Rs 2350 million. It has tied up with German pharmaceutical firm Boehringer Ingelheim for technical and marketing collaboration. It will be a 15,000 sq mt greenfield facility,being designed for process development, fermentation, purification and formulation of biologicals for clinical studies. The plant will consist of a cGMP (current Good Manufacturing Practices)-compliant drug manufacturing facility and, a sterile fill and finish facility for drugs. It will house process development laboratories to support production of protein therapeutics.
